Des-γ-Carboxy Prothrombin (DCP) as a Potential Autologous Growth Factor for the Development of Hepatocellular Carcinoma

Des-γ-carboxy prothrombin (DCP) is a prothrombin precursor produced in hepatocellular carcinoma (HCC). Because of deficiency of vitamin K or γ-glutamyl carboxylase in HCC cells, the 10 glutamic acid (Glu) residues in prothrombin precursor did not completely carboxylate to γ-carboxylated glutamic aci...

Full description

Saved in:
Bibliographic Details
Published inCellular physiology and biochemistry Vol. 34; no. 3; pp. 903 - 915
Main Authors Zhang, Yu-Sheng, Chu, Jia-Hui, Cui, Shu-Xiang, Song, Zhi-Yu, Qu, Xian-Jun
Format Journal Article
LanguageEnglish
Published Basel, Switzerland Cell Physiol Biochem Press GmbH & Co KG 01.01.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Des-γ-carboxy prothrombin (DCP) is a prothrombin precursor produced in hepatocellular carcinoma (HCC). Because of deficiency of vitamin K or γ-glutamyl carboxylase in HCC cells, the 10 glutamic acid (Glu) residues in prothrombin precursor did not completely carboxylate to γ-carboxylated glutamic acid (Gla) residues, leaving some Glu residues remained in N-terminal domain. These prothrombin precursors with Glu residues are called DCPs. DCP displays insufficient coagulation activity. Since Liebman reported an elevated plasma DCP in patients with HCC, DCP has been used in the diagnosis of HCC. Recently, its biological malignant potential has been specified to describe DCP as an autologous growth factor to stimulate HCC growth and a paracrine factor to integrate HCC with vascular endothelial cells. DCP was found to stimulate HCC growth through activation of the DCP-Met-JAK1-STAT3 signaling pathway. DCP might increase HCC invasion and metastasis through activation of matrix metalloproteinase (MMPs) and the ERK1/2 MAPK signaling pathway. DCP has also been found to play a crucial role in the formation of angiogenesis. DCP could increase the angiogenic factors released from HCC and vascular endothelial cells. These effects of DCP in angiogenesis might be related to activation of the DCP-KDR-PLC-γ-MAPK signaling pathway. In this article, we summarized recent studies on DCP in biological roles related to cancer progression and angiogenesis in HCC.
AbstractList Des-γ-carboxy prothrombin (DCP) is a prothrombin precursor produced in hepatocellular carcinoma (HCC). Because of deficiency of vitamin K or γ-glutamyl carboxylase in HCC cells, the 10 glutamic acid (Glu) residues in prothrombin precursor did not completely carboxylate to γ-carboxylated glutamic acid (Gla) residues, leaving some Glu residues remained in N-terminal domain. These prothrombin precursors with Glu residues are called DCPs. DCP displays insufficient coagulation activity. Since Liebman reported an elevated plasma DCP in patients with HCC, DCP has been used in the diagnosis of HCC. Recently, its biological malignant potential has been specified to describe DCP as an autologous growth factor to stimulate HCC growth and a paracrine factor to integrate HCC with vascular endothelial cells. DCP was found to stimulate HCC growth through activation of the DCP-Met-JAK1-STAT3 signaling pathway. DCP might increase HCC invasion and metastasis through activation of matrix metalloproteinase (MMPs) and the ERK1/2 MAPK signaling pathway. DCP has also been found to play a crucial role in the formation of angiogenesis. DCP could increase the angiogenic factors released from HCC and vascular endothelial cells. These effects of DCP in angiogenesis might be related to activation of the DCP-KDR-PLC-γ-MAPK signaling pathway. In this article, we summarized recent studies on DCP in biological roles related to cancer progression and angiogenesis in HCC.
Author Chu, Jia-Hui
Qu, Xian-Jun
Song, Zhi-Yu
Zhang, Yu-Sheng
Cui, Shu-Xiang
Author_xml – sequence: 1
  givenname: Yu-Sheng
  surname: Zhang
  fullname: Zhang, Yu-Sheng
– sequence: 2
  givenname: Jia-Hui
  surname: Chu
  fullname: Chu, Jia-Hui
– sequence: 3
  givenname: Shu-Xiang
  surname: Cui
  fullname: Cui, Shu-Xiang
– sequence: 4
  givenname: Zhi-Yu
  surname: Song
  fullname: Song, Zhi-Yu
– sequence: 5
  givenname: Xian-Jun
  surname: Qu
  fullname: Qu, Xian-Jun
  email: qxj@sdu.edu.cn or quxj@ccmu.edu.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25200250$$D View this record in MEDLINE/PubMed
BookMark eNptkctu1DAUhi1URC-wYI-QJTbtImA7cWIvS4ZepErMAtbWiePMpCQ5g-1A-1y8B8-ES4ZZsbBsH336ftn_KTmacHKEvObsPedSf2CM5WWZM_WMnPBC8ExXlTpKZ8ZlprSqjslpCPcsXSstXpBjIQVjQrIT8rByIfv9K6vBN_jwSNce49bj2PQTPV_V6wsKgQJdY3RT7GGgl3PEATc4B3rt8Wfc0iuwET3t0opbR1fuhxtwNyaeYkdv3A4iWjcM8wCephzbTzjCS_K8gyG4V_v9jHy9-vSlvsnuPl_f1pd3mS0Yi5nIOeSd5k3DywKkBGd5pTUvVKsktEIo1nIouNDAbRqAZmXbOFtVoMqmbfMzcrt4W4R7s_P9CP7RIPTm7wD9xoCPvR2cYYXLpUgeBaooXKdtpaVVHLROkwqS63xx7Tx-n12IZuzD09NgculDDJephJJJzRJ6saDWYwjedYdozsxTaeZQWmLf7rVzM7r2QP5rKQHvFuAb-I3zB6Bef1wUZtd2iXrzX2qf8gfm2qhj
CitedBy_id crossref_primary_10_1016_j_prp_2024_155216
crossref_primary_10_3892_ijo_2020_5035
crossref_primary_10_1080_07357907_2016_1227445
crossref_primary_10_3748_wjg_v30_i17_2343
crossref_primary_10_1007_s10238_018_0528_z
crossref_primary_10_18632_oncotarget_9168
crossref_primary_10_1097_JS9_0000000000000376
crossref_primary_10_3233_THC_231470
crossref_primary_10_1007_s11901_023_00626_3
crossref_primary_10_3389_fonc_2021_726213
crossref_primary_10_1111_hepr_13750
crossref_primary_10_21164_pomjlifesci_477
crossref_primary_10_1155_2018_3120185
crossref_primary_10_1177_1724600818760234
crossref_primary_10_1186_s40001_023_01310_4
crossref_primary_10_24293_ijcpml_v26i2_1436
crossref_primary_10_3390_cancers14061493
crossref_primary_10_3390_cancers16050901
crossref_primary_10_1002_jgh3_12879
crossref_primary_10_1016_j_ejrad_2024_111551
crossref_primary_10_2174_1568009621999210120182834
crossref_primary_10_1371_journal_pone_0265235
crossref_primary_10_3389_fpubh_2021_784718
crossref_primary_10_7717_peerj_15988
crossref_primary_10_1007_s12328_021_01567_4
crossref_primary_10_1186_s43556_024_00184_0
crossref_primary_10_3390_biom13091369
crossref_primary_10_3748_wjg_v25_i36_5515
crossref_primary_10_1111_1440_1681_13745
crossref_primary_10_1038_s41598_024_59174_5
crossref_primary_10_3389_fcell_2020_00055
ContentType Journal Article
Copyright 2014 S. Karger AG, Basel
2014 S. Karger AG, Basel.
Copyright_xml – notice: 2014 S. Karger AG, Basel
– notice: 2014 S. Karger AG, Basel.
DBID M--
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOA
DOI 10.1159/000366308
DatabaseName Karger Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: M--
  name: Karger Open Access
  url: https://www.karger.com/OpenAccess
  sourceTypes:
    Enrichment Source
    Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1421-9778
EndPage 915
ExternalDocumentID oai_doaj_org_article_04e352a1c8a844ef9c795c81a998a87a
10_1159_000366308
25200250
366308
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
0R~
0~B
29B
30W
326
36B
3O.
4.4
53G
5GY
5VS
6J9
8UI
AAFWJ
AAYIC
ACGFO
ACGFS
ADBBV
AENEX
AEYAO
AFPKN
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BCNDV
CS3
CYUIP
DIK
DU5
E0A
E3Z
EBS
EJD
EMB
EMOBN
F5P
FB.
GROUPED_DOAJ
HZ~
IPNFZ
KQ8
KUZGX
M--
ML-
N9A
O1H
O9-
OK1
P2P
RIG
RKO
RNS
SV3
UJ6
3V.
7X7
88E
8FI
8FJ
ABUWG
ADAGL
AFKRA
AIOBO
BENPR
BPHCQ
BVXVI
CAG
CCPQU
CGR
COF
CUY
CVF
ECM
EIF
FYUFA
HMCUK
IAO
IHR
ITC
M1P
NPM
PQQKQ
PROAC
PSQYO
RXVBD
UKHRP
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c400t-231a3f91bb164a55aec1799148d85ad2280d1a4129a1c5ada906dbec77a86bdd3
IEDL.DBID DOA
ISSN 1015-8987
IngestDate Thu Jul 04 20:55:53 EDT 2024
Fri Jun 28 10:42:33 EDT 2024
Thu Sep 26 16:46:56 EDT 2024
Sat Sep 28 08:38:50 EDT 2024
Thu Sep 05 17:59:13 EDT 2024
Thu Aug 29 12:04:42 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Signaling pathways
Angiogenesis
Autologous growth factor
Hepatocellular carcinoma (HCC)
Des-γ-carboxy prothrombin (DCP)
Stimulation
Paracrine factor
Language English
License Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC)
applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
2014 S. Karger AG, Basel.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c400t-231a3f91bb164a55aec1799148d85ad2280d1a4129a1c5ada906dbec77a86bdd3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
OpenAccessLink https://doaj.org/article/04e352a1c8a844ef9c795c81a998a87a
PMID 25200250
PQID 1563060590
PQPubID 23479
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_04e352a1c8a844ef9c795c81a998a87a
karger_primary_366308
pubmed_primary_25200250
proquest_miscellaneous_1563060590
crossref_primary_10_1159_000366308
PublicationCentury 2000
PublicationDate 2014-01-01
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: 2014-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Germany
PublicationTitle Cellular physiology and biochemistry
PublicationTitleAlternate Cell Physiol Biochem
PublicationYear 2014
Publisher Cell Physiol Biochem Press GmbH & Co KG
Publisher_xml – name: Cell Physiol Biochem Press GmbH & Co KG
References Liebman HA, Furie BC, Tong MJ, Blanchard RA, Lo KJ, Lee SD, Coleman MS, Furie B: Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984;310:1427-1431.620174110.1056/NEJM198405313102204
Gao J, Feng X, Inagaki Y, Song P, Kokudo N, Hasegawa K, Sugawara Y, Tang W: Des-γ-carboxy prothrombin and c-Met were concurrently and extensively expressed in hepatocellular carcinoma and associated with tumor recurrence. Biosci Trends 2012;6:153-159.2300696110.5582/bst.2012.v6.4.153
Saito M, Seo Y, Yano Y, Miki A, Yoshida M, Azuma T: A high value of serum des-γ-carboxy prothrombin before hepatocellular carcinoma treatment can be associated with long-term liver dysfunction after treatment. J Gastroenterol 2012;47:1134-1142.2244153310.1007/s00535-012-0577-0
Weitz IC, Liebman HA: Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review. Hepatology 1993;18:990-997.840637410.1002/hep.1840180434
Bertino G, Ardiri AM, Boemi PM, Ierna D, Interlandi D, Caruso L, Minona E, Trovato MA, Vicari S, Li Destri G, Puleo S: A study about mechanisms of des-gamma-carboxy prothrombin‘s production in hepatocellular carcinoma. Panminerva Med 2008;50:221-226.18927526
Ueda N, Shiraha H, Fujikawa T, Takaoka N, Nakanishi Y, Suzuki M, Matsuo N, Tanaka S, Nishina S, Uemura M, Takaki A, Shiratori Y, Yamamoto K: Exon 2 deletion splice variant of gamma-glutamyl carboxylase causes des-gamma-carboxy prothrombin production in hepatocellular carcinoma cell lines. Mol Oncol 2008;2:241-249.1938334510.1016/j.molonc.2008.06.004
Murata K, Sakamoto A: Impairment of clathrin-mediated endocytosis via cytoskeletal change by epithelial to fibroblastoid conversion in HepG2 cells: a possible mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma. Int J Oncol 2008;33:1149-1155.1902074710.3892/ijo_00000104
Inagaki Y, Qi F, Gao J, Qu X, Hasegawa K, Sugawara Y, Tang W, Kokudo N: Effect of c-Met inhibitor SU11274 on hepatocellular carcinoma cell growth. Biosci Trends 2011;5:52-56.2157224710.5582/bst.2011.v5.2.52
Wang SB, Cheng YN, Cui SX, Zhong JL, Ward SG, Sun LR, Chen MH, Kokudo N, Tang W, Qu XJ: Des-gamma-carboxy prothrombin stimulates human vascular endothelial cell growth and migration. Clin Exp Metastasis 2009;26:469-477.1926322910.1007/s10585-009-9246-y
Zhao D, Zhai B, He C, Tan G, Jiang X, Pan S, Dong X, Wei Z, Ma L, Qiao H, Jiang H, Sun X: Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells. Cell Signal 2014;26:1030-1039.2448641210.1016/j.cellsig.2014.01.026
Basilico C, Arnesano A, Galluzzo M, Comoglio PM, Michieli P: A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met. J Biol Chem 2008;283:21267-21277.1849566310.1074/jbc.M800727200
Yamaguchi R, Yano H, Nakashima Y, Ogasawara S, Higaki K, Akiba J, Hicklin DJ, Kojiro M: Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues. Oncol Rep 2000;7:725-729.1085453310.3892/or.7.4.725
Yamashita Y, Tsuijita E, Takeishi K, Fujiwara M, Kira S, Mori M, Aishima S, Taketomi A, Shirabe K, Ishida T, Maehara Y: Predictors for microinvasion of small hepatocellular carcinoma ≤ 2 cm. Ann Surg Oncol 2012;19:2027-2034.2220318410.1245/s10434-011-2195-0
Yamagata H, Nakanishi T, Furukawa M, Okuda H, Obata H: Levels of vitamin K, immunoreactive prothrombin, des-gamma-carboxy prothrombin and gamma-glutamyl carboxylase activity in hepatocellular carcinoma tissue. J Gastroenterol Hepatol 1995;10:8-13.762011310.1111/j.1440-1746.1995.tb01040.x
Miyakawa T, Kajiwara Y, Shirahata A, Okamoto K, Itoh H, Ohsato K: Vitamin K contents in liver tissue of hepatocellular carcinoma patients. Jpn J Cancer Res 2000;91:68-74.1074404610.1111/j.1349-7006.2000.tb00861.x
Sekiya C, Kohda H, Hasebe C, Namiki M, Watanabe K, Naraki T: Characteristics of the PIVKA-II found in hepatocellular carcinoma: Investigation using monoclonal antibodies MU-3 and 19B7. Int Hepatol Commun 1994;2:277-284.10.1016/0928-4346(94)90063-9
Sorciano-Garcia M, Padmanabhan K, de Vos AM, Tullunsky A: The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1. Biochemistry 1992;31:2554-2566.154723810.1021/bi00124a016
Guo RP, Zhong C, Shi M, Zhang CQ, Wei W, Zhang YQ, Li JQ: Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma. J Cancer Res Clin Oncol 2006;132:547-555.1676380510.1007/s00432-006-0097-5
Suzuki H, Murata K, Gotoh T, Kusano M, Okano H, Oyamada T, Yasuda Y, Imamura M, Kudo M, Mizokami M, Sakamoto A: Phenotype-dependent production of des-γ-carboxy prothrombin in hepatocellular carcinoma. J Gastroenterol 2011;46:1219-1229.2174412910.1007/s00535-011-0432-8
Nagaoka S, Yatsuhashi H, Hamada H, Yano K, Matsumoto T, Daikoku M, Arisawa K, Ishibashi H, Koga M, Sata M, Yano M: The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma. Cancer 2003;98:2671-2677.1466928810.1002/cncr.11839
Naraki T, Kohno N, Saito H, Fujimoto Y, Ohhira M, Morita T, Kohgo Y: gamma-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-gamma-carboxy prothrombin. Biochim Biophys Acta 2002;1586:287-298.1199708010.1016/S0925-4439(01)00107-7
Yue P, Gao ZH, Xue X, Cui SX, Zhao CR, Yuan Y, Yin Z, Inagaki Y, Kokudo N, Tang W, Qu XJ: Des-γ-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway. Eur J Cancer 2011;47:1115-1124.2134970110.1016/j.ejca.2011.01.017
Otsuka M, Kato N, Shao RX, Hoshida Y, Ijichi H, Koike Y, Taniguchi H, Moriyama M, Shiratori Y, Kawabe T, Omata M: Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation. Hepatology 2004;40:243-251.1523910810.1002/hep.20260
Hu B, Tian X, Sun J, Meng X: Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis. Int J Mol Sci 2013;14:23559-23580.2431743110.3390/ijms141223559
Gao FJ, Cui SX, Chen MH, Cheng YN, Sun LR, Ward SG, Kokudo N, Tang W, Qu XJ: Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells. Life Sci 2008;83:815-820.1897667410.1016/j.lfs.2008.10.003
Morimoto Y, Nouso K, Wada N, Takeuchi Y, Kinugasa H, Miyahara K, Yasunaka T, Kuwaki K, Onishi H, Ikeda F, Miyake Y, Nakamura S, Shiraha H, Takaki A, Yamamoto K: Involvement of platelets in extra-hepatic metastasis of hepatocellular carcinoma. Hepatol Res 2014; doi: 10.1111/hepr.12315.2455235010.1111/hepr.12315
Fujikawa T, Shiraha H, Ueda N, Takaoka N, Nakanishi Y, Matsuo N, Tanaka A, Sakaguchi K, Shiraton Y: Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration. J Biol Chem 2007;282:8741-8748.1725510210.1074/jbc.M609358200
Sugimoto H, Takeda S, Inoue S, Kaneko T, Watanabe K, Nakao A: Des-gamma-carboxy prothrombin (DCP) ratio, a novel parameter measured by monoclonal antibodies MU-3 and 19B7, as a new prognostic indicator for hepatocellular carcinoma. Liver Int 2003;23:38-44.1264072610.1034/j.1600-0676.2003.01777.x
Muto J, Shirabe K, Sugimachi K, Maehara Y: A review of angiogenesis in hepatocellular carcinoma. Hepatol Res 2014; doi: 10.1111/hepr.12310.2453348710.1111/hepr.12310
Ohhira M, Ohtake T, Saito H, Ikuta K, Tanaka K, Tanabe H, Kawashima T, Fujimoto Y, Naraki T, Ono M, Kohgo Y: Increase of serum des-gamma-carboxy prothrombin in alcoholic liver disease without hepatocellular carcinoma. Alcohol Clin Exp Res 1999;23:67S-70S.1023528210.1111/j.1530-0277.1999.tb04537.x
Murata K, Suzuki H, Okano H, Oyamada T, Yasuda Y, Sakamoto A: Cytoskeletal changes during epithelial-to-fibroblastoid conversion as a crucial mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma. Int J Oncol 2009;35:1005-1014.1978725410.3892/ijo_00000415
Furie B, Furie BC: Molecular basis of vitamin K-dependent gamma-carboxylation. Blood 1990;75:1753-1762.2184900
Marrero JA, Su GL, Emick D, Conjeevaram HS, Fontana RJ, Lok AS: Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients. Hepatology 2003;37:1114-1121.1271739210.1053/jhep.2003.50195
Zhang Q, Bai X, Chen W, Ma T, Hu Q, Liang C, Xie S, Chen C, Hu L, Xu S, Liang T: Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling. Carcinogenesis 2013;34:962-973.2335885210.1093/carcin/bgt027
Bertino G, Ardiri A, Malaguarnera M, Malaguarnera G, Bertino N, Calvagno GS: Hepatocellualar carcinoma serum markers. Semin Oncol 2012;39:410-433.2284685910.1053/j.seminoncol.2012.05.001
Suzuki M, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Nakanishi Y, Koike K, Takaki A, Shiratori Y: Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma. J Biol Chem 2005;280:6409-6415.1558299510.1074/jbc.M406714200
Ratcliffe JV, Furie B, Furie BC: The importance of specific γ-carboxyglutamic acid residues in prothrombin. J Biol Chem 1993;268:24339-24345.8226983
Matsubara M, Shiraha H, Kataoka J, Iwamuro M, Horiguchi S, Nishina S, Takaoka N, Uemura M, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yamamoto K: Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma. J Gastroenterol Hepatol 2012;27:1602-1608.2255429210.1111/j.1440-1746.2012.07173.x
Tanaka T, Taniguchi T, Sannomiya K, Takenaka H, Tomonari T, Okamoto K, Kitamura S, Okahisa T, Tamaki K, Mikasa H, Suzuki S, Takayama T: Novel des-γ-carboxy prothrombin in serum for the diagnosis of hepatocellular carcinoma. J Gastroenterol Hepatol 2013;28:1348-1355.2343234510.1111/jgh.12166
Uehara S, Gotoh K, Handa H, Honjo K, Hirayama A: Process of carboxylation of glutamic acid resid
References_xml
SSID ssj0015792
Score 2.3218973
SecondaryResourceType review_article
Snippet Des-γ-carboxy prothrombin (DCP) is a prothrombin precursor produced in hepatocellular carcinoma (HCC). Because of deficiency of vitamin K or γ-glutamyl...
SourceID doaj
proquest
crossref
pubmed
karger
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 903
SubjectTerms Angiogenesis
Autologous growth factor
Biomarkers - chemistry
Biomarkers, Tumor
Carcinoma, Hepatocellular - diagnosis
Carcinoma, Hepatocellular - physiopathology
Des-γ-carboxy prothrombin (DCP)
Growth Substances - physiology
Hepatocellular carcinoma (HCC)
Humans
Liver Neoplasms - diagnosis
Liver Neoplasms - physiopathology
Molecular Structure
Paracrine factor
Protein Precursors - chemistry
Protein Precursors - physiology
Prothrombin - chemistry
Prothrombin - physiology
Review
Signaling pathways
Stimulation
SummonAdditionalLinks – databaseName: Karger Open Access
  dbid: M--
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Nb9QwELWqogouiH4AgRYZxAEOFpusHSfHNmW7qgTaQyv1Fo1jm0qoSbWkUvu7-j_4TczYSdQi9RgncSKPrXlvPH7D2OfUZsZ5lQkjlRZSey1KA3iZ4WyZW69UQ3HIHz_z5bk8vVAXQ7yDzsL8pvznII06aQugw_0WdFPyOZ3qfZZphNyUpCfEtF-gdBn3NVMlCqTRg4bQo1dJ95dEhjI6Y__ACQWtfnRA8dNPI83gcRav2MsBKvLDaNtttuHaHbYVi0fe7bDn1VirbZfdIn0Uf-9FBWvT3d7x1bqj-gdXSHv5l-Nq9ZXDHw581fWUHESd3oS6tUj7-QkS8f6SL0LhHY4YliMm5A-SiXjn-RK9Vt9RlJ_SVnlFFYja7gr22Pni-1m1FENNBdHgau0FwjmY-zI1BnkSKAWuIU04JEW2UGBJHMemIBEFQNpgA5Sz3KKdtYYiN9bOX7PNtmvdW8Z1k8scAaeV2Uw2BrGcsak3vkBWPVPWJezTOMj1dZTOqAPlUGU9GSVhRzT80wOkdh0auvWvelg89Uw6xIn4QwUUUjpfNrpUTZECckUoNCRsLxpv6mbsfP-_9mp1FG_V19Yn7ONo6hrtRWMIrcORr1NSTcvpXG7C3sQ5MHUxzqF3T3z0PXuBoErGMM0-2-zXN-4AgUtvPoQ5-w9TdeSy
  priority: 102
  providerName: Karger AG
Title Des-γ-Carboxy Prothrombin (DCP) as a Potential Autologous Growth Factor for the Development of Hepatocellular Carcinoma
URI https://karger.com/doi/10.1159/000366308
https://www.ncbi.nlm.nih.gov/pubmed/25200250
https://search.proquest.com/docview/1563060590
https://doaj.org/article/04e352a1c8a844ef9c795c81a998a87a
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlENJLaT7auvlALT20B5GVV7LsY-J0uxRS9tBAbmZkSRRK7LBxIPld-R_5TZmx7GUJlFx6WVitEWZmzLwnz77H2BfpUuuDToVV2ghlghGFBfyaYrVMXdC6pnPI81_Z_EL9vNSXa1ZfNBMW5YFj4I4nyiNGAFnnkCvlQ1GbQte5BOQJkJsIjaQeydTw_kCbIr7nlFrkSKsHTSHs3ce9BEs2JT_JtU7UC_ZjF_pL89fLf8PNvu3M3rI3A17kJ_E-t9kr3-ywzeggeb_DtsrRsG2X3SGHFI8PooSlbe_u-WLZkgnCFXJf_vWsXHzjcMOBL9qOJoRo09vevBa5P_-BbLz7w2e9-w5HIMsRGPK1iSLeBj7H1tW1dNRPs6u8JBuipr2CPXYx-_67nIvBWEHU-Mh2AjEdTEMhrUWyBFqDr0kYDpmRyzU4UshxEhRCAYw7LkAxyRwm2xjIM-vc9B3baNrGf2Dc1JnKEHU6lU5UbRHQWSeDDTlS64l2PmGfxyBX11E_o-p5hy6qVSYSdkrhX11Aktf9AhZCNRRC9VIhJGwvJm-1zbj5wbP1cnEaf6quXUjYpzHVFeaLYgiNx8hXkqTTMvpzbsLexxpYbZGSWhWix4__48732WuEYSoe7BywjW556w8R6nT2qK9q_DwX4glxx_lZ
link.rule.ids 315,786,790,870,2115,27666,27955,27956
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Des-%CE%B3-carboxy+prothrombin+%28DCP%29+as+a+potential+autologous+growth+factor+for+the+development+of+hepatocellular+carcinoma&rft.jtitle=Cellular+physiology+and+biochemistry&rft.au=Zhang%2C+Yu-Sheng&rft.au=Chu%2C+Jia-Hui&rft.au=Cui%2C+Shu-Xiang&rft.au=Song%2C+Zhi-Yu&rft.date=2014-01-01&rft.eissn=1421-9778&rft.volume=34&rft.issue=3&rft.spage=903&rft_id=info:doi/10.1159%2F000366308&rft_id=info%3Apmid%2F25200250&rft.externalDocID=25200250
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1015-8987&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1015-8987&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1015-8987&client=summon